This company seems to have been delisted
Reason: filed for bankruptcy
Last recorded trade on: June 14, 2024
Source: https://www.biopharmadive.com/news/acorda-bankruptcy-asset-sale-merz-stalking-horse/712010/
Reason: filed for bankruptcy
Last recorded trade on: June 14, 2024
Source: https://www.biopharmadive.com/news/acorda-bankruptcy-asset-sale-merz-stalking-horse/712010/
Acorda Therapeutics
ACOR
C$0.90
Share price
0.00%
Change (1 day)
-95.65%
Change (1 year)
Categories
Acorda Therapeutics (ACOR) - Total debt
Total debt on the balance sheet as of March 2024 : C$0.26 Billion
According to Acorda Therapeutics 's latest financial reports the company's total debt is C$0.26 Billion. A company’s total debt is the sum of all current and non-current debts.
Acorda Therapeutics - Total debt on balance sheet (from 2003 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | C$0.23 B | -3.58% |
| 2021-12-31 | C$0.24 B | -26.58% |
| 2020-12-31 | C$0.33 B | 1.67% |
| 2019-12-31 | C$0.32 B | -30.38% |
| 2018-12-31 | C$0.46 B | 11.14% |
| 2017-12-31 | C$0.42 B | -5.29% |
| 2016-12-31 | C$0.44 B | 9.57% |
| 2015-12-31 | C$0.40 B | 20.22% |
| 2014-12-31 | C$0.33 B | 7156.8% |
| 2013-12-31 | C$4.65 M | -13.14% |
| 2012-12-31 | C$5.35 M | -17.36% |
| 2011-12-31 | C$6.48 M | -15.99% |
| 2010-12-31 | C$7.71 M | -5.35% |
| 2009-12-31 | C$8.15 M | -7.4% |
| 2008-12-31 | C$8.8 M | 28.1% |
| 2007-12-31 | C$6.87 M | -23.71% |
| 2006-12-31 | C$9.01 M | -29.53% |
| 2005-12-31 | C$12.78 M | 20.04% |
| 2004-12-31 | C$10.65 M | -2.42% |
| 2003-12-31 | C$10.91 M | |
| 2003-06-30 | C$11.89 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | C$0.92 B | 248.97% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | C$0.81 B | 207.25% | 🇺🇸 USA |
 Affimed
AFMD | C$19.5 M | -92.67% | 🇩🇪 Germany |
 Sarepta Therapeutics
SRPT | C$1.82 B | 585.87% | 🇺🇸 USA |